Pentoxifylline
Pentoxifylline is a pharmaceutical drug with 114 clinical trials. Currently 12 active trials ongoing. Historical success rate of 85.3%.
Success Metrics
Based on 58 completed trials
Phase Distribution
Phase Distribution
19
Early Stage
40
Mid Stage
30
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
81.7%
58 of 71 finished
18.3%
13 ended early
12
trials recruiting
114
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit
Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)
Pentoxifylline in Patients With Ulcerative Colitis
Pentoxifylline in Diabetic Kidney Disease
Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation
Clinical Trials (114)
Pentoxifylline for Prevention of Contrast Induced Nephropathy in Chronic Kidney Diseased Patients in Intensive Care Unit
Pentoxifylline and Tocopherol (PENTO) in the Treatment of Medication-related Osteonecrosis of the Jaw (MRONJ)
Pentoxifylline in Patients With Ulcerative Colitis
Pentoxifylline in Diabetic Kidney Disease
Pneumonitis Prevention Protocol Using Pentoxifylline and α-tocopherol In Stage III Non-Small Cell Lung Cancer Patients Undergoing Chemoradiation
RECLAIM: Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine
Systemic Therapy of Open-label Prophylactic Pravastatin or Pentoxifylline/Tocopherol Prevention of Lymphedema Advancing to Eventual Fibrosis: an Interventional Registry-embedded Bayesian Randomized Trial for Radiation Sequelae (STOP4-LATE-FIBROSE)
Reversing External-beam Radiotherapy-associated Fibrosis Syndrome: an Interventional Bayesian Adaptive Randomized-controlled Orphan Drug Platform Trial for Orodental Sequelae (Reverse-fibrose)
Pentoxifylline on Inflammatory Markers in Non-Diabetic Chronic Kidney Disease Patients
Cocaine and Pentoxifylline (BED IN 47)
Pentoxifylline as Anti-Inflammatory in Patients With Rheumatoid Arthritis
Data Analysis for Drug Repurposing for Effective Alzheimer's Medicines (DREAM)- Pentoxifylline Versus Cilostazol
Evaluation of Efficacy, Safety and Molecular Mechanism of Pentoxifylline Supplementation in Patients With Hepatic and Obstructive Jaundice
Nephroprotection Following Perinatal Asphyxia: Randomized Controlled Trial
The Efficacy of Using Pentoxifylline in Patients Undergoing Breast Cancer Surgery
Metformin Repurposing in Oral Submucous Fibrosis: Unveiling In Vitro Signaling Pathways, Progressing to Clinical Trial
Bioequivalence Study of Pentoxifylline 400 Mg in Healthy Subjects Under Fasting and Fed Conditions
Trental for the Treatment of Vertigo/Dizziness/Imbalance
Pentoxifylline Role Against Chemotherapy-induced Neuropathy
Pentoxifylline Dose Optimization in Neonatal Sepsis
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 114